Association of Low High-Density Lipoprotein Cholesterol Levels with Poor Outcomes in Hepatitis B-Associated Decompensated Cirrhosis Patients
Table 3
Clinical data according to HDL-C levels.
Low group ( mmol/L, )
High group ( mmol/L, )
Gender (female/male)
13/37
17/86
0.242
Age (years)
56.0 (47.0-64.0)
52.0 (46.0-62.0)
0.452
Total protein (g/L)
62.2 (57.5-67.6)
61.2 (56.4-66.5)
0.341
Albumin (g/L)
29.1 (24.3-31.7)
32.1 (27.7-35.5)
0.004
Alanine aminotransferase (U/L)
38.0 (19.0-74.0)
27.0 (16.0-36.8)
0.007
Aspartate aminotransferase (U/L)
71.0 (33.0-113.0)
36.0 (26.8-52.3)
<0.001
Total bilirubin (μmol/L)
97.5 (34.0-199.0)
26.0 (16.0-45.5)
<0.01
Blood urea nitrogen (μmol/L)
5.7 (4.2-7.8)
5.9 (4.4-7.7)
0.590
INR
1.64 (1.30-1.89)
1.26 (1.14-1.48)
<0.01
Serum creatinine (μmol/L)
70.5 (59.0-92.0)
76.0 (62.0-86.8)
0.288
Platelet (×109/L)
80.0 (39.0-138.0)
65.0 (41.3-113.3)
0.510
MELD score
15.4 (11.3-21.1)
9.8 (5.7-12.9)
<0.001
Hemoglobin (g/L)
100.5 (86.0-114.0)
102.0 (83.3-118.8)
0.639
30-day mortality (yes/no)
21/29
8/95
<0.001
Data are expressed as number or median (interquartile range). Abbreviations: INR: international normalized ratio; MELD: Model for End-stage Liver Disease.
